Health Canada inspection
10445517 Canada Inc / North Pharmaceuticals / DAC Pharmaceuticals: Health Canada inspection of Mar 22, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | 10445517 Canada Inc / North Pharmaceuticals / DAC Pharmaceuticals |
|---|---|
| City | Laval |
| Province | Quebec |
| Country | Canada |
| Program | GMP |
| Start date | Mar 22, 2023 |
| End date | Mar 22, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 3-002508 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.